Skip to content

CJC-1295 has no FDA-approved use.

FDA status
Prescribed CJC-1295

CJC-1295 background to bring to a doctor. Nothing is prescribed here.

Menu
Two adults at a breakfast table, one pouring water and one looking down at a book, viewed across the room.

How long-acting CJC-1295 was built and tested

CJC-1295 affects the signals that control growth hormone. Explore what the early studies found, why the DAC form lasts longer, and what remains unknown about its benefits and safety.

  • A GHRH analog
  • DAC changes duration
  • Small human studies
  • No FDA-approved use

What CJC-1295 is

CJC-1295 is a synthetic peptide: a short chain of amino acids made to resemble growth hormone-releasing hormone, or GHRH. It stimulates the pituitary gland to release growth hormone. It is not growth hormone itself.

The best-known human studies examined a long-acting form that attaches to albumin, a protein in blood. They showed sustained changes in hormone levels, rather than proof of better sleep, greater strength or longer life.

An adult stretching beside a bedroom window, seen from behind in soft morning light.

Why DAC changes the question

DAC stands for Drug Affinity Complex. It includes a maleimidopropionic acid linker that allows the peptide to bind albumin. That attachment changes how long the compound stays in circulation.

The long-acting form and the shorter-acting substance often called “CJC-1295 without DAC” cannot be treated as interchangeable. A name without the form leaves an important part of the question unanswered.

Albumin binding and the DAC form A simplified relationship: CJC-1295 with DAC attaches to albumin through a linker. The attachment extends its time in circulation. CJC-1295 with DAC Linker Albumin Longer time in circulation

What the evidence can tell us

The human evidence is small and largely concerns hormone measurements. A change in a blood marker does not establish a health benefit. Safety also needs its own evidence.

The human studies

Early work measured growth hormone, IGF-1 and the time the compound remained in blood. It helps explain the biology, while leaving everyday outcomes uncertain.

Explore the research

The safety questions

Reported reactions, possible immune responses and the consequences of sustained hormone stimulation all matter. Small, short studies cannot settle long-term risks.

Review effects and safety
An empty bedroom in soft evening light, with a cotton cover folded at the foot of the bed.

Sleep, recovery and unanswered questions

People in research-use communities describe changes in sleep, exercise recovery and body composition. These accounts are anecdotal, not clinical evidence. The published human studies did not establish these as benefits of CJC-1295.

The effects page separates those reports from measured findings and explains the safety concerns alongside them.

Find the detail that matters

For the chemical name and the difference between forms, visit the CJC-1295 FAQ. For the quantities used in named studies, see dosage in research. Neither page provides a personal treatment schedule.

For prescription questions, start with access and FDA status. CJC-1295 has no FDA-approved use. A prescription, a compounding rule and FDA approval describe different things; none can substitute for the others.

The references bring together the scientific papers and official documents used throughout the site, with a short explanation of what each source can support.